Granules India: Sethu Madhavan Sankaran resigns as Senior Vice President, Head- API Manufacturing, Operations

Published On 2025-03-01 08:00 GMT   |   Update On 2025-03-01 08:00 GMT

Granules India has announced that Sethu Madhavan Sankaran has resigned from the position of Senior Vice President & Head-API Manufacturing & Operations of the Company.

"Sethu Madhavan Sankaran, shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Senior Vice President & Head- API Manufacturing & Operations with effect from the closure of business hours of February 28, 2025, Granules informed in a BSE filing.

Sethu resigned due to professional reasons and better career prospects.

Sethu Madhavan is a postgraduate in chemical engineering from ICT Mumbai and an executive MBA from MDI Gurgaon. He comes with over 27 years of experience in API manufacturing across biologics and small molecules and has worked with organizations like Biocon, Teva API, Ranbaxy, Dr. Reddy’s Laboratories & Herdilla Chemicals. He has handled various functions like R&D, Operations, Technical Services & Technology Transfer, and Operational Excellence activities in the pharmaceutical industry. He joined Granules India in March 2024.

Read also: Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semiregulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.

Read also: Granules India Riaz Ahmed resigns as Senior Vice President & Head- Supply Chain Management

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News